The newest heart research arrives with a jolt: scientists report that the tools doctors use every day to spot people at risk of a first heart attack often miss the very patients who need help most. This matters now because heart disease remains the world’s leading cause of death, and many victims believe they are low risk until a crisis hits. The study reveals a hidden danger, especially for adults under sixty-five who never receive treatment because their risk scores or symptoms do not raise alarms.
Fast Facts
Finding: New research shows traditional risk scores and symptom-based screening often miss people who later suffer a first heart attack.
Why It Matters: Many “low-risk” patients never receive early evaluation or treatment, highlighting the need for better detection tools.
Study Base: Analysis of 465 real cases shows nearly half would not have qualified for preventive therapy before their event.
The researchers found that nearly half of people who experienced their first major heart attack had been labeled low or borderline risk just two days before their emergency. Many had no chest pain or breathing trouble until hours before it happened. This discovery challenges the idea that standard risk scores and waiting for symptoms can reliably prevent first heart events. It shows how the early stages of artery disease can stay silent while damage quietly builds.
To uncover these patterns, the team reviewed 465 real patient cases from two major U.S. medical centers between 2020 and 2025. They studied medical records, cholesterol levels, blood pressure, and symptoms. They also applied two well-known prediction tools: the ASCVD Risk Estimator Plus and the PREVENT calculator. These tools estimate a person’s chance of developing heart disease. The scientists then asked a simple question: Would these tools have caught the risk if judged 48 hours before the heart attack? Their answer was often no.
This finding matters because it shows a gap between what today’s screening promises and what it delivers. If high-risk individuals slip through unnoticed, they miss early treatment that could prevent a life-threatening event. The study suggests that relying only on symptoms or long-term risk scores may leave many people without needed evaluation or medication. It highlights the need for better ways to detect early artery damage, especially in younger adults who may look healthy on paper.
Experts involved in the study explained why this happens. They said risk calculators often assume heart disease follows a slow and steady path. But plaque buildup in the arteries can rupture suddenly without warning symptoms. As one interpretation in the paper notes, this “MI paradox” occurs because many people with plaque are categorized as low risk when measured only by age, cholesterol levels, or blood pressure. The study team believes more direct detection of artery disease, such as imaging tests, could help catch hidden danger sooner.
This result connects to a larger public-health issue. Heart disease affects millions, and younger adults now show rising rates of first heart attacks. These findings link to broader questions in medicine about how to prevent disease earlier, not just respond once symptoms appear. Better screening could reduce medical costs, improve long-term health, and guide stronger prevention programs. It also fits with global efforts to use better tools, including imaging and new biomarkers, to catch disease earlier across many conditions.
Next, researchers plan to test whether adding imaging like coronary calcium scans, new biomarkers, or improved algorithms can fill this gap. They also want to understand how to offer advanced screening in a cost-effective way. Open questions remain: What is the best age to begin more precise testing? Which groups benefit most? And how can hospitals adopt these tools without overloading patients or healthcare systems? This study opens a path for future work rather than closing the discussion.
The key takeaway is simple but important: the way we screen for first heart attacks needs to change. Many people labeled low risk may still face danger, and symptoms often appear too late for prevention. The new evidence suggests that catching hidden artery disease earlier could help save lives and reduce the global burden of heart attacks.
Story Source:
Materials provided by Mount Sinai Health System. Content may be edited for style and length.
Journal Reference:
Anna S. Mueller, Jonathon Leipsic, Matthew Tomey, Edgar Argulian, Jagat Narula, Amir Ahmadi. Limitations of Risk- and Symptom-Based Screening in Predicting First Myocardial Infarction. JACC: Advances, 2025. DOI: 10.1016/j.jaccadv.2025.102361